Crossmark

Omalizumab for Difficult-to-Treat Dermatological Conditions: Clinical and Immunological Features from a Retrospective Real-Life Experience

Crossref DOI link: https://doi.org/10.1007/s40261-015-0267-9

Published Online: 2015-01-13

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Romano, Ciro

Sellitto, Ausilia

De Fanis, Umberto

Balestrieri, Antonella

Savoia, Alfonso

Abbadessa, Salvatore

Astarita, Corrado

Lucivero, Giacomo
License Information

Text and Data Mining valid from 2015-01-13